lung cancer Archives | Be Korea-savvy
Positive Interim Results of CHOICE-01 Study Evaluating Junshi Biosciences and Coherus’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer

Positive Interim Results of CHOICE-01 Study Evaluating Junshi Biosciences and Coherus’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer

SHANGHAI, China and REDWOOD CITY, Calif., Sept. 14 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus Biosciences, Inc. (Nasdaq: CHRS) announced the presentation today of positive interim results from the pivotal study “CHOICE-01” (NCT03856411), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab plus chemotherapy as [...]

Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer

Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer

SHANGHAI, China, and REDWOOD CITY, Calif., Aug. 18 (Korea Bizwire) —  Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced positive interim results from the pivotal study “CHOICE-01” (NCT03856411), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab plus chemotherapy as first-line treatment of advanced squamous or [...]

Researchers Probe New Territory in Treating Patients with Lung Cancer during COVID-19 Pandemic

Researchers Probe New Territory in Treating Patients with Lung Cancer during COVID-19 Pandemic

Press Briefing with International Researchers Explores this Question at IASLC 2020 World Conference on Lung Cancer Singapore To view a recording of the press briefing, visit: https://vimeo.com/506248459/caa7346336    SINGAPORE, Jan. 29 (Korea Bizwire) — On February 27, 2020, the flagship journal of the International Association for the Study of Lung Cancer, the Journal of Thoracic Oncology, published a [...]

Lung Cancer Care and Research Not Immune to Socioeconomic, Ethnic, Racial, and Gender-related Factors that Create Disparities

Lung Cancer Care and Research Not Immune to Socioeconomic, Ethnic, Racial, and Gender-related Factors that Create Disparities

SINGAPORE, Jan. 28 (Korea Bizwire) — Several leading international lung cancer researchers at a press today presented compelling new data revealing that factors of race, gender, sexual orientation and income continue to be significant barriers to those living with lung cancer. The press briefing is part of the IASLC’s World Conference on Lung Cancer 2020 Singapore.  [...]

Sotorasib Provides Durable Clinical Benefit for Patients with NSCLC and KRAS Mutations

Sotorasib Provides Durable Clinical Benefit for Patients with NSCLC and KRAS Mutations

SINGAPORE, Jan. 28 (Korea Bizwire) — In the phase II CodeBreak 100 trial, sotorasib provided durable clinical benefit with a favorable safety profile in patients with pretreated non-small cell lung cancer (NSCLC) and who harbor KRAS p.G12C mutations, validating CodeBreak 100’s phase I results, according to research presented today at the International Association for the Study of [...]

New Global Survey Shows Misperceptions About Lung Cancer Among the General Public

New Global Survey Shows Misperceptions About Lung Cancer Among the General Public

LONDON, Nov. 27 (Korea Bizwire) — Only one in five people (22%) disagree with the statement “generally, patients with lung cancer have caused their illness through their lifestyle choices and behaviors,” according to a global, omnibus survey conducted by Ipsos MORI and sponsored by the Lung Ambition Alliance. The results were released to coincide with the [...]

Lung Ambition Alliance Unveils New Initiatives to Address Lung Cancer Survival at the World Conference on Lung Cancer

Lung Ambition Alliance Unveils New Initiatives to Address Lung Cancer Survival at the World Conference on Lung Cancer

BARCELONA, Spain, Sept. 7 (Korea Bizwire) — Today, at the IASLC World Conference on Lung Cancer, the four founding partners of the Lung Ambition Alliance – the International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca – announced the launch of several new initiatives to [...]

Lung Ambition Alliance Launches with Goal to Double Five-year Survival in Lung Cancer by 2025

Lung Ambition Alliance Launches with Goal to Double Five-year Survival in Lung Cancer by 2025

LONDON, Jul. 8 (Korea Bizwire) — Today, the International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca announced the Lung Ambition Alliance, a new partnership with a bold ambition to eliminate lung cancer as a cause of death. The first goal of the Alliance will [...]

World Conference on Lung Cancer Wednesday Press Conference: Applying Conference Discoveries and Themes to the Real World

World Conference on Lung Cancer Wednesday Press Conference: Applying Conference Discoveries and Themes to the Real World

TORONTO, Sept. 26 (Korea Bizwire) — The final press briefing from the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC) was led by conference co-presidents Natasha B. Leighl, M.D., BSc, MSc, and Gail Darling M.D., FRCSC, who reviewed the innovative work in lung cancer research and treatment [...]

World Conference on Lung Cancer Tuesday Press Conference: Improving the Cure Rate for Stage III Lung Cancer

World Conference on Lung Cancer Tuesday Press Conference: Improving the Cure Rate for Stage III Lung Cancer

TORONTO, Sept. 25 (Korea Bizwire) — Today’s press conference at the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC) featured some of the year’s most innovative research in both small cell and non-small cell lung cancer. Frances Shepherd, M.D., FRCPC, WCLC honorary chair, medical oncologist at Princess [...]